Ulrich Jaschinski
Augsburg College
43 Papers
285 Citations
Ulrich Jaschinski is an academic researcher from Augsburg College. The author has contributed to research in topics: Intensive care & Medicine. The author has an hindex of 15, co-authored 36 publications.
Chat about Author
Papers
Intensive insulin therapy and pentastarch resuscitation in severe sepsis.
Frank M. Brunkhorst,Christoph Engel,Frank Bloos,Andreas Meier-Hellmann,Max Ragaller,Norbert Weiler,Onnen Moerer,Matthias Gruendling,Michael Oppert,Stefan Grond,Derk Olthoff,Ulrich Jaschinski,Stefan John,Rolf Rossaint,Tobias Welte,Martin Schaefer,Peter M. Kern,Evelyn Kuhnt,Michael Kiehntopf,Christiane S. Hartog,Charles Natanson,Markus Loeffler,Konrad Reinhart +22 more
TL;DR: The use of intensive insulin therapy placed critically ill patients with sepsis at increased risk for serious adverse events related to hypoglycemia and HES was harmful, and its toxicity increased with accumulating doses.
Epidemiology of sepsis in Germany: results from a national prospective multicenter study
Christoph Engel,Frank M. Brunkhorst,Hans-Georg Bone,Reinhard Richard Brunkhorst,Herwig Gerlach,Stefan Grond,Matthias Gruendling,Guenter Huhle,Ulrich Jaschinski,Stefan John,Konstantin Mayer,Michael Oppert,Derk Olthoff,Michael Quintel,Max Ragaller,Rolf Rossaint,Frank Stüber,Norbert Weiler,Tobias Welte,Holger Bogatsch,Christiane S. Hartog,Markus Loeffler,Konrad Reinhart +22 more
TL;DR: The expected number of newly diagnosed cases with severe sepsis in Germany amounts to 76–110 per 100,000 adult inhabitants and future epidemiological studies should use standardized study methodologies with respect to sepsi definitions, hospital size, and daily and monthly variability.
679
Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit
Yasser Sakr,Ulrich Jaschinski,Xavier Wittebole,Tamas Szakmany,Jeffrey Lipman,Silvio A. Ñamendys-Silva,Ignacio Martin-Loeches,Marc Leone,Mary-Nicoleta Lupu,Jean Louis Vincent,Icon Investigators +10 more
TL;DR: There is wide variability in the sepsis rate and outcomes in ICU patients around the globe, and independent risk factors for in-hospital death included older age, higher simplified acute physiology II score, comorbid cancer, chronic heart failure, cirrhosis, use of mechanical ventilation or renal replacement therapy, and infection with Acinetobacter spp.
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial
Alexander Zarbock,Mira Küllmar,Detlef Kindgen-Milles,Carola Wempe,Joachim Gerss,Timo Brandenburger,Thomas Dimski,Bartosz Tyczynski,Michael Jahn,Nils Mülling,Martin Mehrländer,Peter Rosenberger,Gernot Marx,Tim Philipp Simon,Ulrich Jaschinski,Philipp Deetjen,Christian Putensen,Jens-Christian Schewe,Stefan Kluge,Dominik Jarczak,Torsten Slowinski,Marc Bodenstein,Patrick Meybohm,Stefan Wirtz,Onnen Moerer,Andreas Kortgen,Philipp Simon,Sean M. Bagshaw,John A. Kellum,Melanie Meersch,Rich Investigators +30 more
TL;DR: Among critically ill patients with acute kidney injury receiving continuous kidney replacement therapy, anticoagulation with regional citrate, compared with systemic heparin anticoAGulation, resulted in significantly longer filter life span and 90-day mortality.
Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis: A Randomized Trial
Frank M. Brunkhorst,Michael Oppert,Gernot Marx,Frank Bloos,Katrin Ludewig,Christian Putensen,Axel Nierhaus,Ulrich Jaschinski,Andreas Meier-Hellmann,Andreas Weyland,Matthias Gründling,Onnen Moerer,Reimer Riessen,Armin Seibel,Maximilian Ragaller,Markus W. Büchler,Stefan John,Friedhelm Bach,Claudia Spies,Lorenz Reill,Harald Fritz,Michael Kiehntopf,Evelyn Kuhnt,Holger Bogatsch,Christoph Engel,Markus Loeffler,Marin H. Kollef,Konrad Reinhart,Tobias Welte +28 more
TL;DR: In this paper, the authors compared the effect of moxifloxacin and meropenem with the effect on sepsis-related organ dysfunction and concluded that meropenems alone did not result in less organ failure.
230